临床试验/NCT04031612

NCT04031612招募中不适用

Prospective and Retrospective Neoadjuvant Breast Cancer Database

Centre Georges Francois Leclerc1 个研究点分布在 1 个国家目标入组 2,000 人开始时间: 2009年9月9日最近更新: 2019年7月24日

适应症

干预措施

试验速览

阶段: 不适用
状态: 招募中
发起方: Centre Georges Francois Leclerc
入组人数: 2,000
试验地点: 1
主要终点: Patient survival

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The NEOADJ Database base contains data collected during the regular clinical patient management (sociodemographic, clinical, pathological, radiological, biological, disease evolution...). This database allows easy access to information in a centralized and structured way.

This cohort is used to gather insights for research purposes. All data collected come from medical files of patients managed at Centre Georges Francois Leclerc, Dijon, France.

研究设计

研究类型: Observational
观察模型: Other
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•Women followed for breast cancer in Georges Francois Leclerc Center
•Neoadjuvant chemotherapy
•Age >= 18

排除标准

•Metastatic breast cancer

研究组 & 干预措施

Neoadjuvant Breast Cancer

Patients undergoing neoadjuvant therapy for breast cancer

干预措施: Neoadjuvant therapy (Drug)

结局指标

主要结局

Patient survival

时间窗: 5 years

Overall survival and evolution over years

次要结局

Collection of patient and treatment characteristics(5 years)

研究者

发起方

Centre Georges Francois Leclerc

申办方类型

Other

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

Unknown

不适用

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast CarcinomaBreast Cancer

NCT04021069Sunnybrook Health Sciences Centre800

招募中

不适用

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma

NCT06320717Roswell Park Cancer Institute100

尚未招募

不适用

Neoadjuvant Treatment of Breast CancerBreast Cancer

NCT05131893National Institute of Oncology, Hungary300

Unknown

不适用

TME Neoadjuvant Breast RegistryBreast NeoplasmsBreast Cancer

NCT02596724Targeted Medical Education1,000

已完成

不适用

Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic ImagingBreast Cancer

NCT02510456Boston Medical Center24